Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Psoriasis: HELP
Articles by Lorena Estrada-Aguilar
Based on 1 article published since 2010
(Why 1 article?)
||||

Between 2010 and 2020, Lorena Estrada-Aguilar wrote the following article about Psoriasis.
 
+ Citations + Abstracts
1 Guideline [Mexican treatment goals for plaque psoriasis]. 2017

Estrada-Aguilar, Lorena / Amaya-Guerra, Mario / Gómez-Flores, Minerva / Guevara-Sanginés, Esther / Jurado-Santacruz, Fermín / Lopeztello-Santillán, Adriana / Maldonado-García, César / Rivera-Gómez, Mónica / Rodríguez-Martínez, Norma / Vega-González, Luis. ·Servicio de Dermatología, Hospital Regional Lic. Adolfo López Mateos, ISSSTE, Ciudad de México, México. lorenaestradaaguilar@prodigy.net.mx. ·Rev Med Inst Mex Seguro Soc · Pubmed #28092253.

ABSTRACT: Psoriasis is a chronic inflammatory disease with a worldwide prevalence between 6 and 39% in moderate to severe forms. In European countries like Germany and England was identified that only one third of patients with moderate to severe forms will receive systemic management, this fact motivated to integrate into Europe an international consensus on treatment goals with the aim of providing support to the dermatologist by algorithms that serve as a therapeutic guide that allows you to gain control short and long term effects of this disease. The European group met to develop the definitions of severity of psoriasis, treatment goals for moderate to severe disease, and optimization options and / or therapeutic transition than a paper published in 2011 was obtained. In Mexico a working group of experts on biological therapy (GTEB), made up of 10 members and an extended group of 150 dermatologists' voters in the country for the purpose of issuing Mexico's position on the proposals of the European group was formed. In this document the findings of the Working Group of Experts on Biological Therapy in Mexico are listed.